Majority of Australian Diagnostic Imaging Clinics Now Owned by For-Profit Corporations, New Study Finds

A new study reveals that over 50% of Australia's diagnostic imaging clinics are owned by for-profit corporations, raising critical concerns about healthcare costs, access, and quality.
A recent comprehensive national audit has highlighted a significant shift in the ownership landscape of Australia's diagnostic imaging sector. The findings reveal that more than half of the imaging clinics across the country are now owned by large for-profit corporations. Led by Dr. Sean Docking from Monash University's School of Public Health and Preventive Medicine, the research uncovered that eight major corporations collectively control 51% of all diagnostic imaging clinics in Australia. This ownership concentration is particularly pronounced in states and territories like South Australia, Tasmania, the Northern Territory, and the Australian Capital Territory, where single companies hold a market share of 30% or more of non-government facilities.
Diagnostic imaging services—including X-ray, ultrasound, and MRI—play a crucial role in early diagnosis and patient care. The sector is valued at approximately $6 billion, making it an attractive investment for private equity and corporate entities. The recent acquisition of private hospital chain Healthscope by private equity investors has intensified scrutiny over this sector.
The dominance of corporate ownership raises numerous concerns regarding healthcare access, cost escalation, service overuse, and whether the financial objectives of these companies align with broader public health goals. Notably, the sale of Australia's leading imaging provider, I-Med, for nearly $3 billion, exemplifies the growing influence of private entities.
Ownership of MRI services, one of the most profitable imaging modalities, is especially concentrated among four companies, which control over half of the Medicare-rebatable MRI clinics nationwide. Since these services largely rely on taxpayer-funded Medicare rebates, there's an urgent need for government oversight to ensure accountability and high-value care.
This research provides a vital foundation for ongoing investigations into how corporatization impacts healthcare delivery and its value to the public. It underscores the importance of balancing private investment with policies that safeguard equitable and cost-effective health services.
Source: https://medicalxpress.com/news/2025-06-reveals-majority-australian-diagnostic-imaging.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Genetic Markers and Vitamin B3 Offer Hope in Managing MASLD Progression
Researchers identify a genetic regulator, microRNA-93, that worsens MASLD, with vitamin B3 showing promise as an effective treatment to counteract disease progression.
Federal Cuts in Enforcement Staff and Suspension of Black Lung Disease Prevention Rules Impact Coal Miners' Safety
In 2025, federal agency staffing reductions and regulatory delays have compromised protections against black lung disease in coal miners, raising serious health and safety concerns amid ongoing legal and administrative challenges.
groundbreaking milestone: First Patient Receives Personalized CRISPR Gene Therapy for a Rare Genetic Disorder
A groundbreaking milestone in personalized medicine: Children's Hospital of Philadelphia successfully treats a child with a rare genetic disorder using customized CRISPR gene editing, opening new horizons for targeted therapies.
Innovative Universal Flu Vaccine Could End the Need for Annual Shots
A new universal influenza vaccine developed by researchers aims to provide long-lasting protection against swine, human, and bird flu, potentially ending the need for annual flu shots.